NAVIN FLUORINE INTERNATIONAL LTD.
NSE : NAVINFLUORBSE : 532504ISIN
CODE : INE048G01026Industry : ChemicalsHouse
: Arvind Mafatlal
BSE3308.455.45 (+0.17 % )
PREV CLOSE (Rs.) 3303.00
OPEN PRICE (Rs.) 3310.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5579
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE3309.75 2.9 (+0.09 % )
PREV CLOSE(Rs.) 3306.85
OPEN PRICE (Rs.) 3310.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 3309.75 (248 )
VOLUME 314560
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Company News
| Date | Heading | Details |
|---|---|---|
| 01-Apr-2024 | Navin Fluorine International informs about analyst meet | <div>Navin Fluorine International has informed that the officials of Navin Fluorine International Limited ('the Company') will be interacting with Analysts / Investors on April 05, 2024 at 11.30 A.M. (IST). Presentation to be made at the Meeting is enclosed. Discussions will be based on publicly available information. This intimation is also being made available on the Company's website at www.nfil.in.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 20-Mar-2024 | Navin Fluorine International informs about board meeting | <div>Navin Fluorine International has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 07, 2024, to consider, approve and take on record, the Annual Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ending March 31, 2024; and to consider and recommend final dividend for the Financial Year 2023-2024. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their immediate relatives, the Trading Window in respect of dealings in the securities of the Company will remain closed from March 31, 2024 to May 09, 2024 (both days inclusive).</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 15-Mar-2024 | Navin Fluorine International to further invest Rs 250 crore in NFASL | <p style="text-align: justify;">Navin Fluorine International has received an approval for additional investment of around Rs 250 crore in Navin Fluorine Advanced Sciences (NFASL), Wholly Owned Subsidiary, by subscribing to Non-Cumulative, Non-Convertible, Non-participating, Redeemable Preference Shares for repayment of the existing Inter Corporate Deposits and further business funding requirements of NFASL. </p><p style="text-align: justify;">The Board of Directors of the Company at its meeting held on March 14, 2024, has based on the recommendation of the Audit Committee, approved the same. NFASL has been incorporated on February 06, 2020 in India by the Company for greenfield projects in fluorochemicals. NFASL has commenced its commercial operation in the financial year 2022-2023.</p><p style="text-align: justify;">Navin Fluorine International is primarily focuses on fluorine chemistry - producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers Contract Research and Manufacturing Services.</p><div style="text-align: justify;"><br></div> |
| 15-Mar-2024 | Navin Fluorine International informs about loss of share certificates | <div style="text-align: justify;">Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Navin Fluorine International has informed that the Company has received an intimation today, March 15, 2024 from KFin Technologies, the Company's RTA, regarding loss of share certificates and issue of letter of confirmations and in that respect, relevant details are enclosed. Accordingly, letter of confirmations will be issued in lieu of duplicate share certificates only after the necessary formalities are carried out.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE. </div> |
| 26-Feb-2024 | Conversion of Stock Option | Inter alia, approved :- 1) Capital Expenditure The Board has approved Capital Expenditure of: (a) Rs288 crores for new cGMP-4 facility at Dewas unit of the Company, to be spent in two or more phases; and (b) Rs 84 crores for expansion of HFC capacity at Surat unit of the Company. 2) Grant of Options under Employees? Stock Option Scheme 2017 The Board has granted 40,000 stock options to the employees of the Company under Employees? Stock Option Scheme 2017. |
| 14-Feb-2024 | Navin Fluorine International informs about analyst meet | <div>Navin Fluorine International has informed that the officials of Navin Fluorine International ('the Company') will be interacting with Analysts / Investors on February 19, 2024 at 4.00 PM (IST). Presentation to be made at the Meeting is enclosed. Discussions will be based on publicly available information. This intimation is also being made available on the Company's website at www.nfil.in</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 13-Feb-2024 | Navin Fluorine International informs about earnings call transcript | <div>Navin Fluorine International has informed that it enclosed Transcript of Earnings Call held for the quarter ended December 31, 2023.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 07-Feb-2024 | Navin Fluorine International gets nod for capex of Rs 372 crore | <p style="text-align: justify;">Navin Fluorine International has received approval for capital expenditure of Rs 288 crore for new cGMP-4 facility at Dewas unit of the Company, to be spent in two or more phases and for Rs 84 crore for expansion of HFC capacity at Surat unit of the Company. The Board of Directors of the Company at its meeting held on February 06, 2024 approved the same. </p><p style="text-align: justify;">Navin Fluorine International is primarily focuses on fluorine chemistry - producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers Contract Research and Manufacturing Services.</p> |
| 06-Feb-2024 | Grant Of Options Under Employees' Stock Option Scheme 2017 | Grant of Options under Employees'' Stock Option Scheme 2017 |
| 05-Feb-2024 | Grant Of Options Under Employees' Stock Option Scheme 2017 | Grant of Options under Employees'' Stock Option Scheme 2017 |
